STAAR Surgical Company (STAA)
After hours:
| Previous Close | 100.63 |
| Open | 100.59 |
| Bid | 100.32 x 1300 |
| Ask | 107.77 x 800 |
| Day's Range | 97.65 - 101.71 |
| 52 Week Range | 49.03 - 163.08 |
| Volume | |
| Avg. Volume | 447,143 |
| Market Cap | 4.827B |
| Beta (5Y Monthly) | 1.08 |
| PE Ratio (TTM) | 147.78 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
LAKE FOREST, Calif., August 10, 2022--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced its partnership with singer, songwriter, and actor, Joe Jonas, to raise awareness of its EVO Visian® Implantable Collamer® Lenses (EVO). EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia and astigmatism. Joe Jonas had myopia since childhood, which is
- Business Wire
STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
LAKE FOREST, Calif., August 10, 2022--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 1, 2022.
- Business Wire
STAAR Surgical to Report Second Quarter Results on August 10, 2022
LAKE FOREST, Calif., July 20, 2022--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 1, 2022 on Wednesday, August 10, 2022 after the market close.
